Rapid multiplexed detection of beta-amyloid and total-tau as biomarkers for Alzheimer's disease in cerebrospinal fluid.

This paper reports the multiplexed monitoring of two promising biomarkers, beta-amyloid (Aβ42) and total tau (T-tau), in both buffer and cerebrospinal fluid (CSF) for Alzheimer's disease (AD) using label-free optical nanosensors. It has been found that 7.8 pg/ml of Aβ42 in buffer and 15.6 pg/ml of T-au in buffer can be readily detected with very good specificity. Based on our measurements, the purchased CSF itself contains Aβ42, whose concentration is estimated to be about 400 pg/ml. Aβ42 and T-tau in the mixtures of Aβ42 and T-tau spiked in CSF have been detected successfully, indicating the feasibility of the optical nanosensors to detect these biomarkers in clinical samples. For the measurements, only a small amount (~1 μl) of the samples is required. This type of sensor is suitable for point-of-care application to diagnose the AD due to its low cost and ease-of-operation.

[1]  Tianhua Zhang,et al.  A nanostructured Fabry-Perot interferometer. , 2010, Optics express.

[2]  K. Blennow,et al.  Basic Research , 2022 .

[3]  L. Que,et al.  Fabrication and characterization of aluminum oxide thin film micropatterns on the glass substrate , 2014 .

[4]  G. Whitesides,et al.  Soft Lithography. , 1998, Angewandte Chemie.

[5]  L. Sola,et al.  Development of a high-sensitivity immunoassay for amyloid-beta 1-42 using a silicon microarray platform. , 2013, Biosensors & bioelectronics.

[6]  S. Prasad,et al.  CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[7]  L. Que,et al.  A polymer nanostructured Fabry-Perot interferometer based biosensor. , 2011, Biosensors & bioelectronics.

[8]  W. M. van der Flier,et al.  Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. , 2010, Clinical chemistry.

[9]  J. Trojanowski,et al.  Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease. , 2012, Methods.

[10]  L. Que,et al.  Nanostructured optical microchips for cancer biomarker detection. , 2012, Biosensors & bioelectronics.

[11]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[12]  Arti Vashist,et al.  Nano-biosensors to detect beta-amyloid for Alzheimer's disease management. , 2016, Biosensors & bioelectronics.

[13]  R. Dean,et al.  A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics , 2016, Alzheimer's Research & Therapy.

[14]  L. Que,et al.  A transparent nanostructured optical biosensor. , 2014, Journal of biomedical nanotechnology.

[15]  Y. Youn,et al.  Cerebrospinal Fluid β-Amyloid1–42 Levels in the Differential Diagnosis of Alzheimer’s Disease—Systematic Review and Meta-Analysis , 2015, PloS one.

[16]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.